| The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance O Tapia, I Riquelme, P Leal, A Sandoval, S Aedo, H Weber, P Letelier, ... Virchows Archiv 465, 25-33, 2014 | 203 | 2014 |
| Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy I Riquelme, K Saavedra, JA Espinoza, H Weber, P García, B Nervi, ... Oncotarget 6 (28), 24750, 2015 | 158 | 2015 |
| Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy C Bizama, P García, JA Espinoza, H Weber, P Leal, B Nervi, JC Roa Cancer Treatment Reviews 41 (3), 222-234, 2015 | 72 | 2015 |
| AKT/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines P Leal, P Garcia, A Sandoval, K Buchegger, H Weber, O Tapia, JC Roa OncoTargets and therapy, 1373-1384, 2013 | 42 | 2013 |
| Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer H Weber, JR Valbuena, MA Barbhuiya, S Stein, H Kunkel, P García, ... Oncotarget 8 (16), 26169, 2017 | 29 | 2017 |
| Hippo-YAP1 is a prognosis marker and potentially targetable pathway in advanced gallbladder cancer P García, L Rosa, S Vargas, H Weber, JA Espinoza, F Suárez, ... Cancers 12 (4), 778, 2020 | 22 | 2020 |
| Low expression of equilibrative nucleoside transporter 1 is associated with poor prognosis in chemotherapy‐naïve pT2 gallbladder adenocarcinoma patients JA Espinoza, P García, C Bizama, JL Leal, I Riquelme, H Weber, ... Histopathology 68 (5), 722-728, 2016 | 19 | 2016 |
| Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice H Weber, P Leal, S Stein, H Kunkel, P García, C Bizama, JA Espinoza, ... Oncotarget 6 (31), 31877, 2015 | 19 | 2015 |
| CRISPR/Cas13-based platforms for a potential next-generation diagnosis of colorectal cancer through exosomes micro-RNA detection: a review B Durán-Vinet, K Araya-Castro, J Calderón, L Vergara, H Weber, ... Cancers 13 (18), 4640, 2021 | 17 | 2021 |
| Extracts of deschampsia antarctica desv, with antineoplastic activity M Gidegel, H Weber, G Cabrera, A Gutierrez, J Osorio, J Becera, ... US Patent App. 12/734,597, 2010 | 15 | 2010 |
| Mucin 5B, carbonic anhydrase 9 and claudin 18 are potential theranostic markers of gallbladder carcinoma JA Espinoza, I Riquelme, EA Sagredo, L Rosa, P García, C Bizama, ... Histopathology 74 (4), 597-607, 2019 | 14 | 2019 |
| A Novel CDC25B Promoter–Based Oncolytic Adenovirus Inhibited Growth of Orthotopic Human Pancreatic Tumors in Different Preclinical Models HL Weber, M Gidekel, S Werbajh, E Salvatierra, C Rotondaro, L Sganga, ... Clinical Cancer Research 21 (7), 1665-1674, 2015 | 13 | 2015 |
| Bacteria and boar semen storage: progress and challenges MJ Contreras, K Núñez-Montero, P Bruna, M García, K Leal, L Barrientos, ... Antibiotics 11 (12), 1796, 2022 | 11 | 2022 |
| Controlled release of caffeic acid and pinocembrin by use of nPSi-βCD composites improves their antiangiogenic activity D Guzmán-Oyarzo, J Hernández-Montelongo, C Rosas, P Leal, H Weber, ... Pharmaceutics 14 (3), 484, 2022 | 5 | 2022 |
| Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor P García, C Bizama, L Rosa, JA Espinoza, H Weber, J Cerda-Infante, ... Biological Research 53, 1-17, 2020 | 5 | 2020 |
| Therapeutic targets of monoclonal antibodies used in the treatment of cancer: Current and emerging B Effer, I Perez, D Ulloa, C Mayer, F Muñoz, D Bustos, C Rojas, ... Biomedicines 11 (7), 2086, 2023 | 3 | 2023 |
| Advances towards the use of gastrointestinal tumor patient-derived organoids as a therapeutic decision-making tool J Obreque, L Vergara-Gómez, N Venegas, H Weber, GI Owen, ... Biological Research 56 (1), 63, 2023 | 2 | 2023 |
| A novel gemcitabine-resistant gallbladder cancer model provides insights into molecular changes occurring during acquired resistance L Vergara-Gómez, C Bizama, J Zhong, K Buchegger, F Suárez, L Rosa, ... International journal of molecular sciences 24 (8), 7238, 2023 | 2 | 2023 |
| Controlled release of caffeic acid and pinocembrin by use of nPSi-βCD composites improves their antiangiogenic activity. Pharmaceutics. 2022; 14 (3) D Guzmán-Oyarzo, J Hernández-Montelongo, C Rosas, P Leal, H Weber, ... s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2022 | 2 | 2022 |
| PpIX synthesis increases PDT resistant cells due to the modulating effect of EGCG on the heme synthesis pathway D León, Á Gutiérrez, H Weber, R Silva, ME Reyes, T Viscarra, ... Cancer Research 83 (7_Supplement), 2845-2845, 2023 | 1 | 2023 |
JUAN CARLOS ROAPONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Professor and Chair Department of Pathology.在 med.puc.cl 的电子邮件经过验证
